Organigram improves compassionate care access for patients through enhanced OrganiCare program

This information was provided by prnewswire

Send your Press Release here.

Ease of access initiative makes it easier to qualify, also decreases the burden of medicinal cost for qualified patients

MONCTON, NB, Jan. 23, 2019 /CNW/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis is pleased to announce it has made changes to its compassionate care model by developing OrganiCare, a program designed to improve access to medical cannabis for low-income patients.

Effective immediately, patients who earn an annual income less than $35,000 per year qualify for OrganiCare, the Company’s new program that offers qualified patients a 30 per cent price reduction on all dried cannabis products and oils.

Previously, compassionate pricing was offered to individuals earning less than $30,000 per year and offered a 25 per cent price reduction.

“We understand cost can be a barrier to medication for patients,” says Greg Engel, CEO, Organigram. “It is important to us to do what we can to improve access for patients who need it the most. It’s our hope that OrganiCare will allow a greater number of patients to access their medicine.”

Organigram’s Compassionate Care Program was voted best in Canada at the Canadian Cannabis Awards in 2017.

“With this change, this support program solidifies Organigram’s position as the most accessible medical cannabis provider for low-income Canadians,” Engel says.

Patients who are already enrolled in the program need not reapply. Patients who wish to apply for the first time must validate their annual income with attestation documents from a federal or provincial authority, including Canada Revenue Agency or a disability support program. Information on how to apply can be found at

Emerald contributor since March 2012


Your email address will not be published.